Menu
Your Cart

Good News

31 Mar Good news | T&L CGT core raw material CD28 monoclonal antibody has completed FDA DMF filingNew Blog Post
TL.admin 0 309
Recently, T&L Biotechnology Ltd. (referred to as "T&L") successfully obtained the US FDA DMF registration for its CGT core raw material CD28 monoclonal antibody, with DMF registration number 038820.Your cell therapy research project can directly refe..
02 Aug Good news | T&L cell therapy key materials have been registered with FDA DMF, helping your drug application process
TL.admin 1 677
Recently, T&L Biotechnology Ltd. (hereinafter referred to as "T&L") received a confirmation letter from the US Food and Drug Administration (hereinafter referred to as "FDA"), stating that the company's key raw materials for cell therapy drugs, CD3 m..
Showing 1 to 2 of 2 (1 Pages)